Journals / Anadolu Kardiyoloji Dergisi / 2004 / Cilt: 4 - Sayı: 1

Epidemiological and pharmacological profile of congestive heart failure at Turkish Academic Hospitals

Pages
32–38
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

İskemiye bağlı KKY erkeklerde daha sık (%72 karşı %46, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Amaç: Konjestif kalp yetersizliği (KKY) tedavisinde Türkiyede üniversite hastanelerinde uygulanan tedavi yöntemlerini araştırmaktır.Yöntem: Çalışmaya 16 üniversite hastanesinde retrospektif olarak incelenen 661 hasta alındı.
📊
Key Findings & Data:Bulgular: Çalışma hastalarımızın yaş ortalamaları 61±12 yıl, hastanede ortalama kalış süreleri 10±6 gündü.
💡
Conclusion & Impact:İskemiye bağlı KKY erkeklerde daha sık (%72 karşı %46, p
🔬Design:Research Article
📍Scope:661 hasta
⚙️Variables:Domain Parameters

Abstract

Amaç: Konjestif kalp yetersizliği (KKY) tedavisinde Türkiyede üniversite hastanelerinde uygulanan tedavi yöntemlerini araştırmaktır.Yöntem: Çalışmaya 16 üniversite hastanesinde retrospektif olarak incelenen 661 hasta alındı. Hastaların hastaneye kabulden önceki, hastanede kaldıkları süre içindeki tedavileri, fonksiyonel durumu, KKY’nin etyolojisi ve laboratuar bulguları incelenerek kaydedildi. Bulgular: Çalışma hastalarımızın yaş ortalamaları 61±12 yıl, hastanede ortalama kalış süreleri 10±6 gündü. İskemiye bağlı KKY erkeklerde daha sık (%72 karşı %46, p

🔖

Cite This Article

TOPSAKAL, R., ERYOL, N. K., DELİCEO, A., SEYFELİ, E., ERGİN, A., ÜNAL, Ş. (2022). Epidemiological and pharmacological profile of congestive heart failure at Turkish Academic Hospitals. Anadolu Kardiyoloji Dergisi, Cilt: 4 - Sayı: 1, 32–38. https://ajindex.com/articles/437469

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6
  2. McMurray JJV, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596-602
  3. Mosterd A, Hoes AW, Bruyne MC at al. Prevalence of heart failure and left ventricular dysfunction in the general population. Eur Heart J 1999;20:447-55
  4. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993;14:1158-62 5. The SOLVD investigattors. Effect of enalapril on mortality and development of heart failure in symptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91
  5. Sutton GC. Epidemiologic aspects of heart failure. Am Heart J 1990;120:1538-40
  6. Cowie MR.Annotated references in epidemiology. Eur J Heart Failure 1999;1:101-7
  7. Flather M, Yusuf S, Kober L et al. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-8
  8. Williams JF Jr, Hlatky MA, Bristow MR, et al. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart association task force on practice guidelines (committee on evaluation and management of heart failure). J Am Coll Cardiol 1996;26:1376-98
  9. Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc 1985;33:595-601
  10. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33
  11. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993;329:1-7
  12. Uretsky BF, Young JB, Shahidi FE. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED Trial. J Am Coll Cardiol 1993;22:955-62
  13. Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J 1998;135:367-72
  14. Lechat P. Prevention of heart failure progression: current approaches. Eur Heart J 1998;19 (Suppl B): B12-8
  15. CONSENSUS Trial Study Group: effects